Bill Few Associates
PFE icon

Bill Few Associates’s Pfizer PFE Stock Holding History

Bill Few Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.58M Sell
90,587
-534
-0.6% -$14.2K 0.53% 51
2026
Q2 		$2.19M Sell
91,121
-932
-1% -$24.4K 0.47% 56
2026
Q1 		$2.58M Buy
92,053
+6,511
+8% +$173K 0.62% 45
2025
Q4 		$2.13M Buy
85,542
+1,606
+2% +$40.5K 0.52% 50
2025
Q3 		$2.14M Sell
83,936
-320
-0.4% -$7.9K 0.55% 47
2025
Q2 		$2.04M Buy
84,256
+1,957
+2% +$45.6K 0.58% 46
2025
Q1 		$2.09M Buy
82,299
+2,783
+3% +$72.8K 0.75% 39
2024
Q4 		$2.11M Sell
79,516
-7,247
-8% -$197K 0.74% 40
2024
Q3 		$2.51M Buy
86,763
+2,931
+3% +$85.5K 0.89% 33
2024
Q2 		$2.35M Buy
83,832
+1,224
+1% +$33.7K 0.9% 34
2024
Q1 		$2.29M Buy
82,608
+2,571
+3% +$71.3K 0.93% 30
2023
Q4 		$2.3M Sell
80,037
-783
-1% -$23.7K 1.05% 27
2023
Q3 		$2.68M Buy
80,820
+368
+0.5% +$13K 1.4% 23
2023
Q2 		$2.95M Buy
80,452
+2,225
+3% +$86.6K 1.53% 23
2023
Q1 		$3.19M Buy
78,227
+1,932
+3% +$83.4K 1.77% 19
2022
Q4 		$3.91M Buy
76,295
+2,211
+3% +$106K 2.31% 12
2022
Q3 		$3.24M Buy
74,084
+203
+0.3% +$9.9K 2.19% 15
2022
Q2 		$3.87M Sell
73,881
-1,486
-2% -$75.7K 2.48% 9
2022
Q1 		$3.9M Buy
75,367
+1,079
+1% +$56K 2.12% 14
2021
Q4 		$4.39M Buy
+74,288
New +$3.68M 2.27% 13

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Bill Few Associates's PFE Position: Q3 2026 in Review

Bill Few Associates reduced its Pfizer (PFE) stake by 0.59% in Q3 2026, selling an estimated $14.2K and leaving 90,587 shares worth $2.58M. The position accounts for 0.53% of the portfolio, ranked #51.

Bill Few Associates first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $4.39M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Bill Few Associates held 90,587 shares of Pfizer worth $2.58M as of Q3 2026.
  • Bill Few Associates sold 534 Pfizer shares in Q3 2026, an estimated $14.2K.
  • Pfizer made up 0.53% of Bill Few Associates's portfolio in Q3 2026, its #51 holding.
  • Bill Few Associates first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • Bill Few Associates's Pfizer position peaked at $4.39M in Q4 2021.
  • 1,037 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.